2019 NephCure Award Recipients
NEPTUNE Ancillary Studies Grant Awardee
DANIELLA LEVY EREZ, MD, MTR
Does the T-cell lymphocyte profile in patients with Nephrotic Syndrome predict response to Rituximab
Dr. Levy Erez graduated from Medical School at Ben Gurion University in Israel and completed her pediatric residency at Schneider Children’s Medical Center in Petach Tikva, Israel. She moved with her husband and children to the United States to pursue an academic research career. She completed her pediatric nephrology fellowship at the Children’s Hospital of Philadelphia and received her Master’s in translational research at the University of Pennsylvania. Dr. Daniella Levy Erez has experience being both a clinician and a translational researcher. For most of her residency, she cared for Nephrotic Syndrome patients who had received immune therapies and newly transplanted patients who had just received kidney transplants. Her early clinical exposure to renal disease sparked an interest in immunology and pediatric nephrology. Her research is focused on identifying immune biomarkers in kidney disease.
CureGN Pilot Project Grant Awardees
KIRK CAMPBELL, MD
Targetable biomarkers for glomerular disease
Dr. Kirk Campbell is an Associate Professor of Medicine and Director of the Nephrology Fellowship Program at the Icahn School of Medicine at Mount Sinai. He received his medical degree from the University of Connecticut and completed a residency in internal medicine at Yale University. He then completed a clinical and research fellowship in Nephrology at the Mount Sinai Medical Center in New York. In addition to treating patients with kidney disease, Dr. Campbell leads an NIH-funded research program. The program aims to identify therapeutic drug targets for protein-spilling kidney diseases through improved understanding of the mechanisms regarding podocyte injury. He actively participates in clinical trials testing novel agents for primary glomerular diseases.
SCOTT E. WENDERFER, MD, PhD
The C1q Nephropathy Study
Dr. Wenderfer is an Associate Professor of Pediatrics at Baylor College of Medicine (BCM). He received his MD and PhD degrees from the University of Cincinnati as well as training in pediatrics and pediatric nephrology at the University of Texas in Houston. As a staff nephrologist at Texas Children’s Hospital, he treats children with all forms of glomerular disease. Dr. Wenderfer leads a research team that performs clinical and translational studies on complement and antibody-mediated kidney diseases. He is a member of the Pediatric Nephrology Research Consortium (PNRC) and a site investigator for the Cure Glomerulopathy Network (CureGN). Current efforts in his laboratory focus on genetic and autoimmune causes of subsets of patients with Nephrotic Syndrome, such as those with C1q Nephropathy.